Your browser doesn't support javascript.
loading
SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
Elkharsawi, Ahmed; Arnim, Ulrike von; Schmelz, Renate; Sander, Cornelia; Stallmach, Andreas; Teich, Niels; Walldorf, Jens; Reuken, Philipp A.
Affiliation
  • Elkharsawi A; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
  • Arnim UV; Department of Gastroenterology, Hepatology and Infectious diseases, Universitätsklinikum Magdeburg AöR, Magdeburg, Germany.
  • Schmelz R; Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany.
  • Sander C; Deutsche Morbus Crohn/Colitis Ulcerosa Vereinigung e.V., Berlin, Germany.
  • Stallmach A; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
  • Teich N; Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten, Leipzig, Germany.
  • Walldorf J; Department of Internal Medicine I, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Reuken PA; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Z Gastroenterol ; 60(1): 77-80, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35042256
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / COVID-19 Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis / COVID-19 Limits: Humans Language: En Year: 2022 Type: Article